{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T04:23:15Z","timestamp":1777350195650,"version":"3.51.4"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"am","delay-in-days":299,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000061","name":"National Institutes of Health Fogarty International Center","doi-asserted-by":"publisher","award":["D43 TW010540"],"award-info":[{"award-number":["D43 TW010540"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01 DA033679"],"award-info":[{"award-number":["R01 DA033679"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01 DA054851"],"award-info":[{"award-number":["R01 DA054851"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.josat.2025.209640","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T16:44:55Z","timestamp":1740069895000},"page":"209640","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Exploration of the multi-level barriers to scaling up methadone for HIV prevention among people who inject drugs in Kazakhstan"],"prefix":"10.1016","volume":"172","author":[{"given":"Amanda R.","family":"Liberman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yelena","family":"Rozental","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roman","family":"Ivasiy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ainur Zh.","family":"Kussainova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sholpan","family":"Primbetova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn M.","family":"Madden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Assel","family":"Terlikbayeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick L.","family":"Altice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.josat.2025.209640_bb0005","author":"[Clinical Protocol for the Diagnosis and Treatment of Mental and Behavioral Disorders Due to Opioid Use Opiate Agonist Maintenance Therapy]"},{"key":"10.1016\/j.josat.2025.209640_bb0010","author":"[Draft Clinical Protocol for the Diagnosis and Treatment of Mental and Behavioral Disorders Caused by Opioid Use]"},{"key":"10.1016\/j.josat.2025.209640_bb0015","unstructured":"AIDSinfo | UNAIDS. (n.d.). Retrieved April 5, 2024, from https:\/\/aidsinfo.unaids.org\/."},{"issue":"3","key":"10.1016\/j.josat.2025.209640_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000423","article-title":"Effectiveness and cost effectiveness of expanding harm reduction and antiretroviral therapy in a mixed HIV epidemic: A modeling analysis for Ukraine","volume":"8","author":"Alistar","year":"2011","journal-title":"PLoS Medicine"},{"key":"10.1016\/j.josat.2025.209640_bb0025","series-title":"The Lancet psychiatry","first-page":"852","article-title":"Collaborative learning and response to opioid misuse and HIV prevention in Ukraine during war","volume":"Vol. 9, Issue 11","author":"Altice","year":"2022"},{"issue":"9738","key":"10.1016\/j.josat.2025.209640_bb0030","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0140-6736(10)60829-X","article-title":"Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs","volume":"376","author":"Altice","year":"2010","journal-title":"The Lancet"},{"issue":"6","key":"10.1016\/j.josat.2025.209640_bb0035","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1080\/00952990.2021.1979991","article-title":"The impact of relaxation of methadone take-home protocols on treatment outcomes in the COVID-19 era","volume":"47","author":"Amram","year":"2021","journal-title":"American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.josat.2025.209640_bb0040","series-title":"Addiction","first-page":"1869","article-title":"Balancing access and safety in prescribing opioid agonist therapy to prevent HIV transmission","volume":"Vol. 110, Issue 12","author":"Bachireddy","year":"2015"},{"key":"10.1016\/j.josat.2025.209640_bb0045","series-title":"BMC research notes","first-page":"1","article-title":"Effective implementation of research into practice: An overview of systematic reviews of the health literature","volume":"Vol. 4, Issue 1","author":"Boaz","year":"2011"},{"issue":"10","key":"10.1016\/j.josat.2025.209640_bb0050","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1111\/add.12243","article-title":"At the crossroads: HIV prevention and treatment for people who inject drugs in Ukraine","volume":"108","author":"Bojko","year":"2013","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.josat.2025.209640_bb0055","first-page":"255","article-title":"\u201cBureaucracy & Beliefs\u201d: Assessing the barriers to accessing opioid substitution therapy by people who inject drugs in Ukraine","volume":"22","author":"Bojko","year":"2015","journal-title":"Drugs: Education, Prevention and Policy"},{"key":"10.1016\/j.josat.2025.209640_bb0060","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jsat.2016.03.003","article-title":"The future of opioid agonist therapies in Ukraine: A qualitative assessment of multilevel barriers and ways forward to promote retention in treatment","volume":"66","author":"Bojko","year":"2016","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"3","key":"10.1016\/j.josat.2025.209640_bb0065","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/135910457000100301","article-title":"Back-translation for cross-cultural research","volume":"1","author":"Brislin","year":"1970","journal-title":"Journal of Cross-Cultural Psychology"},{"key":"10.1016\/j.josat.2025.209640_bb0070","series-title":"The Lancet regional health - Europe","article-title":"Medications for opioid use disorder during war in Ukraine: Innovations in public and private clinic cooperation","volume":"Vol. 20","author":"Bromberg","year":"2022"},{"issue":"5","key":"10.1016\/j.josat.2025.209640_bb0075","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1177\/15248399231169791","article-title":"Improving HIV and HCV testing in substance use disorder programs (SUDs) that provide medications for opiate use disorder (MOUD): Role of addressing barriers and implementing universal and site-specific approaches","volume":"24","author":"Brooks","year":"2023","journal-title":"Health Promotion Practice"},{"key":"10.1016\/j.josat.2025.209640_bb0080","author":"Bureau of National Statistics Agency for Strategic Planning and Reforms of the Republic of Kazakhstan"},{"key":"10.1016\/j.josat.2025.209640_bb0085","series-title":"International journal of infectious diseases","first-page":"510","article-title":"Prevalence of HIV, HCV and HBV in Central Asia and the Caucasus: A systematic review","volume":"Vol. 104","author":"Davlidova","year":"2021"},{"key":"10.1016\/j.josat.2025.209640_bb0090","series-title":"The Lancet","first-page":"1560","article-title":"Global patterns of opioid use and dependence: Harms to populations, interventions, and future action","volume":"Vol. 394, Issue 10208","author":"Degenhardt","year":"2019"},{"issue":"5","key":"10.1016\/j.josat.2025.209640_bb0095","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1177\/15248399231169928","article-title":"Challenges to achieving HCV micro-elimination in people with HIV in the United States: Provider perspectives and the role of implicit bias","volume":"24","author":"DiDomizio","year":"2023","journal-title":"Health Promotion Practice"},{"key":"10.1016\/j.josat.2025.209640_bb0100","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jsat.2018.07.014","article-title":"Re-engineering methadone\u2014Cost-effectiveness analysis of a patient-centered approach to methadone treatment","volume":"94","author":"Dunlap","year":"2018","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.josat.2025.209640_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12954-022-00703-8","article-title":"Using nominal group technique to identify barriers and facilitators to preventing HIV using combination same-day pre-exposure prophylaxis and medications for opioid use disorder","volume":"19","author":"Eger","year":"2022","journal-title":"Harm Reduction Journal"},{"issue":"1","key":"10.1016\/j.josat.2025.209640_bb0110","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/add.15115","article-title":"The real-world impact of dosing of methadone and buprenorphine in retention on opioid agonist therapies in Ukraine","volume":"116","author":"Farnum","year":"2021","journal-title":"Addiction"},{"key":"10.1016\/j.josat.2025.209640_bb0115","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jsat.2018.06.012","article-title":"Assessing long-term sustainment of clinic participation in NIATx200: Results and a new methodological approach","volume":"92","author":"Ford","year":"2018","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2025.209640_bb0120","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jsat.2014.10.001","article-title":"Effect of an organizational linkage intervention on staff perceptions of medication-assisted treatment and referral intentions in community corrections","volume":"50","author":"Friedmann","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.josat.2025.209640_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2288-13-117","article-title":"Using the framework method for the analysis of qualitative data in multi-disciplinary health research","volume":"13","author":"Gale","year":"2013","journal-title":"BMC Medical Research Methodology"},{"issue":"2","key":"10.1016\/j.josat.2025.209640_bb0130","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.pnpbp.2010.12.002","article-title":"Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance","volume":"35","author":"Gerra","year":"2011","journal-title":"Progress in Neuro-Psychopharmacology and Biological Psychiatry"},{"issue":"4","key":"10.1016\/j.josat.2025.209640_bb0135","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s10461-016-1413-y","article-title":"Social network strategies to address HIV prevention and treatment continuum of care among at-risk and HIV-infected substance users: A systematic scoping review","volume":"21","author":"Ghosh","year":"2017","journal-title":"AIDS and Behavior"},{"issue":"9","key":"10.1016\/j.josat.2025.209640_bb0140","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1001\/jama.2022.1271","article-title":"Association between increased dispensing of opioid agonist therapy take-home doses and opioid overdose and treatment interruption and discontinuation","volume":"327","author":"Gomes","year":"2022","journal-title":"JAMA\u202f: The Journal of the American Medical Association"},{"issue":"2","key":"10.1016\/j.josat.2025.209640_bb0145","doi-asserted-by":"crossref","first-page":"148","DOI":"10.2471\/BLT.12.109553","article-title":"Mitigating the risk of HIV infection with opioid substitution treatment","volume":"91","author":"Gowing","year":"2013","journal-title":"Bulletin of the World Health Organization"},{"key":"10.1016\/j.josat.2025.209640_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2022.108801","article-title":"Treatment retention, return to use, and recovery support following COVID-19 relaxation of methadone take-home dosing in two rural opioid treatment programs: A mixed methods analysis","volume":"141","author":"Hoffman","year":"2022","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2025.209640_bb0155","author":"HRI"},{"key":"10.1016\/j.josat.2025.209640_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.1044677","article-title":"Responding to health policy recommendations on managing opioid use disorder during Russia\u2019s invasion of Ukraine: Divergent responses from the frontline to the west","volume":"10","author":"Ivasiy","year":"2023","journal-title":"Frontiers in Public Health"},{"key":"10.1016\/j.josat.2025.209640_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.dadr.2022.100075","article-title":"Implementation opportunities for scaling up methadone maintenance treatment in Kyrgyzstan: Methadone dosage and retention on treatment over two years","volume":"4","author":"Ivasiy","year":"2022","journal-title":"Drug and Alcohol Dependence Reports"},{"issue":"9","key":"10.1016\/j.josat.2025.209640_bb0170","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1111\/add.16565","article-title":"The impact of emergency guidance to the COVID-19 pandemic on treatment entry, retention and mortality among patients on methadone in Ukraine","volume":"119","author":"Ivasiy","year":"2024","journal-title":"Addiction"},{"key":"10.1016\/j.josat.2025.209640_bb0175","series-title":"Improving healthcare quality in Europe","first-page":"265","article-title":"Audit and feedback as a quality strategy","author":"Jamtvedt","year":"2019"},{"key":"10.1016\/j.josat.2025.209640_bb0180","author":"Joint UN Programme on HIV\/AIDS"},{"key":"10.1016\/j.josat.2025.209640_bb0185","unstructured":"Kazakhstan Union for PLHIV, ITPCru, Central Asian Association of PLHIV, & Public Foundation AGEP'C. (n.d.). Information | Pereboi. Retrieved January 17, 2023, from https:\/\/pereboi.kz\/information\/."},{"key":"10.1016\/j.josat.2025.209640_bb0190","series-title":"Journal of agromedicine","first-page":"295","article-title":"Breadth of the socio-ecological model","volume":"Vol. 22, Issue 4","author":"Kilanowski","year":"2017"},{"key":"10.1016\/j.josat.2025.209640_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2022.103644","article-title":"Impact of the COVID-19 pandemic on the provision of take-home doses of opioid agonist therapy in Ontario, Canada: A population-based time-series analysis","volume":"103","author":"Kitchen","year":"2022","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.josat.2025.209640_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109703","article-title":"Methadone-involved overdose deaths in the United States before and during the COVID-19 pandemic","volume":"242","author":"Kleinman","year":"2023","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2025.209640_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2024.104540","article-title":"Using nominal group technique to identify perceived barriers and facilitators to improving uptake of the Prison Needle Exchange Program in Canadian federal prisons by correctional officers and healthcare workers","volume":"130","author":"Kronfli","year":"2024","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.josat.2025.209640_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2024.104549","article-title":"Using nominal group technique with people who are incarcerated in Canadian federal prisons to identify barriers and solutions to improving Prison Needle Exchange Program uptake","volume":"131","author":"Lafferty","year":"2024","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.josat.2025.209640_bb0215","series-title":"Current psychiatry reports","article-title":"HIV, drug injection, and harm reduction trends in Eastern Europe and Central Asia: Implications for international and domestic policy","volume":"Vol. 21, Issue 7","author":"LaMonaca","year":"2019"},{"key":"10.1016\/j.josat.2025.209640_bb0220","article-title":"Interest without uptake: A mixed-methods analysis of methadone utilization in Kyrgyz prisons","volume":"17(10 October), e0276723","author":"Liberman","year":"2022","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.josat.2025.209640_bb0225","doi-asserted-by":"crossref","first-page":"69","DOI":"10.31389\/jied.208","article-title":"Stalled scale-up of opioid agonist therapies for HIV prevention in Kazakhstan: History, policy, and recommendations for change","volume":"5","author":"Liberman","year":"2024","journal-title":"Journal of Illicit Economies and Development"},{"issue":"8","key":"10.1016\/j.josat.2025.209640_bb0230","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1093\/cid\/ciw416","article-title":"Impact of opioid substitution therapy on antiretroviral therapy outcomes: A systematic review and meta-analysis","volume":"63","author":"Low","year":"2016","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.josat.2025.209640_bb0235","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.drugpo.2017.07.025","article-title":"Using nominal group technique among clinical providers to identify barriers and prioritize solutions to scaling up opioid agonist therapies in Ukraine","volume":"49","author":"Madden","year":"2017","journal-title":"International Journal of Drug Policy"},{"issue":"8","key":"10.1016\/j.josat.2025.209640_bb0240","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1111\/add.14198","article-title":"An investigation of an open-access model for scaling up methadone maintenance treatment","volume":"113","author":"Madden","year":"2018","journal-title":"Addiction"},{"key":"10.1016\/j.josat.2025.209640_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2023.110714","article-title":"Scaling up opioid agonist therapies in Ukraine before the war: Implementation factors related to disruptions from legislative reform and COVID-19","volume":"260","author":"Madden","year":"2024","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2025.209640_bb0250","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.drugpo.2017.05.037","article-title":"Willingness to pay for opioid agonist treatment among opioid dependent people who inject drugs in Ukraine","volume":"45","author":"Makarenko","year":"2017","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.josat.2025.209640_bb0255","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.drugalcdep.2016.06.011","article-title":"Determinants of willingness to enroll in opioid agonist treatment among opioid dependent people who inject drugs in Ukraine","volume":"165","author":"Makarenko","year":"2016","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1016\/j.josat.2025.209640_bb0260","first-page":"163","article-title":"In their own voices: Breaking the vicious cycle of addiction, treatment and criminal justice among people who inject drugs in Ukraine","volume":"23","author":"Mazhnaya","year":"2016","journal-title":"Drugs: Education, Prevention and Policy"},{"key":"10.1016\/j.josat.2025.209640_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108164","article-title":"Rapid transitional response to the COVID-19 pandemic by opioid agonist treatment programs in Ukraine","volume":"121","author":"Meteliuk","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.josat.2025.209640_bb0270","first-page":"33","article-title":"Opioid agonist treatment for opioid use disorder patients in central asia","volume":"23","author":"Michels","year":"2021","journal-title":"Heroin Addiction and Related Clinical Problems"},{"issue":"3","key":"10.1016\/j.josat.2025.209640_bb0275","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/add.14797","article-title":"Cost-effectiveness of expanding the capacity of opioid agonist treatment in Ukraine: Dynamic modeling analysis","volume":"115","author":"Morozova","year":"2020","journal-title":"Addiction"},{"key":"10.1016\/j.josat.2025.209640_bb0280","series-title":"Implementation Science","first-page":"1","article-title":"Systematic review of the exploration, preparation, implementation, sustainment (EPIS) framework","volume":"Vol. 14, Issue 1","author":"Moullin","year":"2019"},{"issue":"6","key":"10.1016\/j.josat.2025.209640_bb0285","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.drugpo.2014.03.007","article-title":"Mortality of registered drug users in Central Asia","volume":"25","author":"Mravcik","year":"2014","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.josat.2025.209640_bb0290","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jsat.2019.01.019","article-title":"Using nominal group technique to identify barriers, facilitators, and preferences among patients seeking treatment for opioid use disorder: A needs assessment for decision making support","volume":"100","author":"Muthulingam","year":"2019","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2025.209640_bb0295","series-title":"The Lancet HIV","first-page":"e617","article-title":"Global HIV control: Is the glass half empty or half full?","volume":"Vol. 10, Issue 9","author":"Nachega","year":"2023"},{"key":"10.1016\/j.josat.2025.209640_bb0300","article-title":"Multi-level implementation factors that influence scale-up of methadone maintenance treatment in Moldovan prisons: A qualitative study","volume":"136","author":"O\u2019hara","year":"2021","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2025.209640_bb0305","series-title":"Health research policy and systems","first-page":"1","article-title":"Strategies for the implementation of clinical practice guidelines in public health: An overview of systematic reviews","volume":"Vol. 20, Issue 1","author":"Pereira","year":"2022"},{"issue":"9","key":"10.1016\/j.josat.2025.209640_bb0310","doi-asserted-by":"crossref","first-page":"5669","DOI":"10.3390\/ijerph20095669","article-title":"Barriers and facilitators to pre-exposure prophylaxis by men who have sex with men and community stakeholders in Malaysia","volume":"20","author":"Rosen","year":"2023","journal-title":"International Journal of Environmental Research and Public Health"},{"key":"10.1016\/j.josat.2025.209640_bb0315","series-title":"Risk management and healthcare policy","first-page":"209","article-title":"The evolving semashko model of primary health care: The case of the Russian Federation","volume":"Vol. 11","author":"Sheiman","year":"2018"},{"issue":"2","key":"10.1016\/j.josat.2025.209640_bb0320","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1016\/S2352-3018(19)30373-X","article-title":"Effect of expanding opioid agonist therapies on the HIV epidemic and mortality in Ukraine: A modelling study","volume":"7","author":"Tan","year":"2019","journal-title":"Lancet HIV"},{"key":"10.1016\/j.josat.2025.209640_bb0325","unstructured":"The NIATx Model. (n.d.). Retrieved September 22, 2022, from https:\/\/chess.wisc.edu\/niatx\/Content\/ContentPage.aspx?PNID=1&NID=8."},{"key":"10.1016\/j.josat.2025.209640_bb0330","series-title":"Drugs and alcohol today","first-page":"124","article-title":"The influence of global players on the drug control system: An analysis of the role of the Russian Federation","volume":"Vol. 17, Issue 2","author":"Tinasti","year":"2017"},{"key":"10.1016\/j.josat.2025.209640_bb0335","series-title":"Methadone: Evil or good? What will happen to substitution therapy for drug addicts","author":"Weber","year":"2021"},{"key":"10.1016\/j.josat.2025.209640_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.lana.2023.100636","article-title":"Retention and critical outcomes among new methadone maintenance patients following extended take-home reforms: A retrospective observational cohort study","volume":"28","author":"Williams","year":"2023","journal-title":"The Lancet Regional Health - Americas"},{"key":"10.1016\/j.josat.2025.209640_bb0345","author":"World Health Organization (WHO) - UNODOC - UNAIDS"},{"issue":"5","key":"10.1016\/j.josat.2025.209640_bb0350","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/cid\/ciaa142","article-title":"Modeling combination hepatitis C virus treatment and prevention strategies in a network of people who inject drugs in the United States","volume":"72","author":"Zelenev","year":"2021","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.josat.2025.209640_bb0355","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.drugpo.2016.08.008","article-title":"The complex interplay of social networks, geography and HIV risk among Malaysian Drug Injectors: Results from respondent-driven sampling","volume":"37","author":"Zelenev","year":"2016","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.josat.2025.209640_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2023.104250","article-title":"Social networks, secondary syringe exchange, and opioid agonist therapy retention among people who inject drugs in Hartford, CT","volume":"123","author":"Zelenev","year":"2024","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.josat.2025.209640_bb0365","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.drugalcdep.2018.05.027","article-title":"Assessment of barrier severity and willingness to enter opioid agonist treatment among people who inject drugs in Ukraine","volume":"190","author":"Zelenev","year":"2018","journal-title":"Drug and Alcohol Dependence"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875925000190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875925000190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T02:48:21Z","timestamp":1745030901000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875925000190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":73,"alternative-id":["S2949875925000190"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2025.209640","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploration of the multi-level barriers to scaling up methadone for HIV prevention among people who inject drugs in Kazakhstan","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2025.209640","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"209640"}}